TUESDAY, May 17 (HealthDay News) -- Some men with enlarged
prostate may not be receiving sufficient treatment and could suffer
severe complications as a result, according to a new study.
Although more men are receiving oral treatment for enlarged
prostate, the rate of men operated on for the condition declined
over a nine-year period and the rate of discharges for men for
enlarged prostate with acute kidney failure has skyrocketed,
researchers found.
Non-cancerous enlargement of the prostate -- called benign
prostatic hyperplasia (BPH) -- is a common condition that affects
millions of men in the United States each year. It can cause lower
urinary tract symptoms ranging from frequent and painful urination
to urinary retention, which can lead to kidney failure if left
untreated.
Treatments include oral therapies and minimally invasive
surgery.
In this analysis of U.S. hospital patient data, University of
California, San Diego researchers found that the prevalence of BPH
increased between 1998 and 2007 but discharges of patients treated
for primary BPH decreased.
During that same period, discharges for patients who had surgery
for BPH decreased 51 percent, discharges for patients with primary
BPH with acute renal (kidney) failure increased more than 300
percent, and discharges for primary BPH with urinary retention,
stones, or infection remained about the same.
The study was slated to be presented Tuesday during a special
press conference at the American Urological Association's annual
scientific meeting.
"Oral therapies for BPH are a common first-line treatment that can be effective in many men. However, it is imperative that patients be treated promptly if the drugs aren't working," press conference moderator Dr. Kevin McVary said in a news release.
"In many cases, surgical treatment for BPH can help prevent urinary retention, which can ultimately lead to acute renal failure that can be life-threatening," he added.
Because the study is being presented at a medical meeting, the
results should be considered preliminary until published in a
peer-reviewed journal.
More information
The U.S. National Institute of Diabetes and Digestive and Kidney
Diseases has more about
prostate enlargement.